secwatch.observer — SEC 8-K summary
======================================

Issuer:     Hepion Pharmaceuticals, Inc. (HEPA)
CIK:        0001583771
Form:       8-K
Filed at:   2025-01-15T23:59:59+00:00
Accession:  0001493152-25-002377
Event type: regulatory
Sentiment:  negative
Materiality: 0.60
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Hepion Pharma receives Nasdaq delisting notice for failure to hold annual meeting; 45 days to submit compliance plan
--------------------------------------------------------------------------------

- Notice dated January 14, 2025 from Nasdaq for failing to hold annual shareholders' meeting within 12 months of fiscal year end.
- Company has 45 days to submit a plan to regain compliance; intends to do so.
- If plan accepted, Nasdaq may grant extension to June 30, 2025; if not, company can appeal.
- Common stock (HEPA) continues trading on Nasdaq Capital Market during the process.
- No assurance that listing will be maintained.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1583771/000149315225002377/0001493152-25-002377-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1583771/000149315225002377/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-25-002377

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer